Atara Biotherapeutics, Inc. (0HIY.L)

USD 7.88

(1.39%)

Total Assets Summary of Atara Biotherapeutics, Inc.

  • Atara Biotherapeutics, Inc.'s latest annual total assets in 2023 was 165.5 Million USD , down -56.03% from previous year.
  • Atara Biotherapeutics, Inc.'s latest quarterly total assets in 2024 Q2 was 117.28 Million USD , down -29.04% from previous quarter.
  • Atara Biotherapeutics, Inc. reported annual total assets of 376.42 Million USD in 2022, down -19.59% from previous year.
  • Atara Biotherapeutics, Inc. reported annual total assets of 468.12 Million USD in 2021, down -20.4% from previous year.
  • Atara Biotherapeutics, Inc. reported quarterly total assets of 165.27 Million USD for 2024 Q1, down -0.14% from previous quarter.
  • Atara Biotherapeutics, Inc. reported quarterly total assets of 302.08 Million USD for 2023 Q1, down -19.75% from previous quarter.

Annual Total Assets Chart of Atara Biotherapeutics, Inc. (2023 - 2012)

Historical Annual Total Assets of Atara Biotherapeutics, Inc. (2023 - 2012)

Year Total Assets Total Assets Growth
2023 165.5 Million USD -56.03%
2022 376.42 Million USD -19.59%
2021 468.12 Million USD -20.4%
2020 588.12 Million USD 71.49%
2019 342.94 Million USD -12.48%
2018 391.83 Million USD 79.93%
2017 217.77 Million USD -17.48%
2016 263.91 Million USD -18.79%
2015 324.97 Million USD 206.23%
2014 106.12 Million USD 104.76%
2013 51.82 Million USD 1108.11%
2012 4.29 Million USD 0.0%

Peer Total Assets Comparison of Atara Biotherapeutics, Inc.

Name Total Assets Total Assets Difference
uniQure N.V. 831.68 Million USD 80.1%
Abeona Therapeutics Inc. 64 Million USD -158.592%
Aclaris Therapeutics, Inc. 197.4 Million USD 16.16%
Agios Pharmaceuticals, Inc. 937.11 Million USD 82.339%
Cara Therapeutics, Inc. 125.84 Million USD -31.515%
Imunon, Inc. 21.91 Million USD -655.103%
Dynavax Technologies Corporation 997.09 Million USD 83.401%
Editas Medicine, Inc. 499.15 Million USD 66.843%
FibroGen, Inc. 423.52 Million USD 60.923%
Iovance Biotherapeutics, Inc. 780.35 Million USD 78.791%
Kala Pharmaceuticals, Inc. 55.94 Million USD -195.812%
Neurocrine Biosciences, Inc. 3.25 Billion USD 94.91%
Sarepta Therapeutics, Inc. 3.26 Billion USD 94.93%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 88.254%
Verastem, Inc. 149.71 Million USD -10.544%
Zoetis Inc. 14.28 Billion USD 98.841%
Vertex Pharmaceuticals Incorporated 22.73 Billion USD 99.272%
Sangamo Therapeutics, Inc. 165.32 Million USD -0.111%
Homology Medicines, Inc. 47.05 Million USD -251.71%
Nektar Therapeutics 398.03 Million USD 58.42%
Viking Therapeutics, Inc. 368.49 Million USD 55.086%
Unity Biotechnology, Inc. 65.69 Million USD -151.947%
Perrigo Company plc 10.8 Billion USD 98.469%
Esperion Therapeutics, Inc. 205.79 Million USD 19.579%
Walgreens Boots Alliance, Inc. 81.03 Billion USD 99.796%
Illumina, Inc. 10.11 Billion USD 98.363%
Thermo Fisher Scientific Inc. 98.72 Billion USD 99.832%
IQVIA Holdings Inc. 26.68 Billion USD 99.38%
Heron Therapeutics, Inc. 222.5 Million USD 25.618%
Waters Corporation 4.62 Billion USD 96.423%
Biogen Inc. 26.84 Billion USD 99.383%
Evolus, Inc. 188.99 Million USD 12.431%
Adicet Bio, Inc. 207.29 Million USD 20.16%
bluebird bio, Inc. 619.16 Million USD 73.27%
Geron Corporation 394.07 Million USD 58.002%
Alnylam Pharmaceuticals, Inc. 3.82 Billion USD 95.679%
Amicus Therapeutics, Inc. 777.88 Million USD 78.724%
Myriad Genetics, Inc. 1.19 Billion USD 86.193%
Intellia Therapeutics, Inc. 1.3 Billion USD 87.278%
Mettler-Toledo International Inc. 3.35 Billion USD 95.068%
Corbus Pharmaceuticals Holdings, Inc. 28.27 Million USD -485.391%
BioMarin Pharmaceutical Inc. 6.84 Billion USD 97.581%
Regeneron Pharmaceuticals, Inc. 33.08 Billion USD 99.5%
Agilent Technologies, Inc. 10.76 Billion USD 98.462%
OPKO Health, Inc. 2.01 Billion USD 91.773%
Exelixis, Inc. 2.94 Billion USD 94.375%
Corcept Therapeutics Incorporated 621.51 Million USD 73.371%
Anavex Life Sciences Corp. 154.38 Million USD -7.201%
Axsome Therapeutics, Inc. 588.23 Million USD 71.864%
Ionis Pharmaceuticals, Inc. 2.99 Billion USD 94.465%
Halozyme Therapeutics, Inc. 1.73 Billion USD 90.451%
Blueprint Medicines Corporation 1.04 Billion USD 84.226%
Insmed Incorporated 1.32 Billion USD 87.555%
TG Therapeutics, Inc. 329.58 Million USD 49.784%
Incyte Corporation 6.78 Billion USD 97.56%
Emergent BioSolutions Inc. 1.83 Billion USD 90.98%